Microbot Medical (FRA:CY9D) Cyclically Adjusted FCF per Share: €-1.73 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CY9D Microbot Medical Inc FRA:CY9D
37 GF Score
Price €1.50
! 2 Warning Signs
View Full Analysis

What is Microbot Medical Cyclically Adjusted FCF per Share?

Microbot Medical FRA:CY9D +7.94% 37 Cyclically Adjusted FCF per Share is €-1.73 as of Mar. 2026. GuruFocus rates FRA:CY9D with a GF Score™ of 37/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Microbot Medical's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.066. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-1.73 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Microbot Medical's average Cyclically Adjusted FCF Growth Rate was -118.80% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 78.30% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 66.00% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 46.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Microbot Medical was 78.30% per year. The lowest was 4.00% per year. And the median was 12.70% per year.

As of today (2026-08-02), Microbot Medical's current stock price is €1.495. Microbot Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-1.73. Microbot Medical's Cyclically Adjusted Price-to-FCF of today is .


Microbot Medical  (FRA:CY9D) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Microbot Medical Cyclically Adjusted FCF per Share Related Terms


Microbot Medical Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Microbot Medical's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbot Medical Cyclically Adjusted FCF per Share Chart

Microbot Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -358.24 -233.89 -118.60 -18.65 -2.12

Microbot Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.67 24.22 39.62 -2.12 -1.73

FRA:CY9D vs STXS, DXR, KRMD: Cyclically Adjusted FCF per Share Comparison

For the Medical Instruments & Supplies subindustry, Microbot Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbot Medical Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Microbot Medical's Cyclically Adjusted Price-to-FCF falls into.


FRA:CY9D
37GF Score
Microbot Medical Inc FRA:CY9D
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Microbot Medical Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Microbot Medical's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.066/330.2130*330.2130
=-0.066

Current CPI (Mar. 2026) = 330.2130.

Microbot Medical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.540 241.018 -0.740
201609 -3.827 241.428 -5.234
201612 -0.010 241.432 -0.014
201703 -0.407 243.801 -0.551
201706 -0.659 244.955 -0.888
201709 -0.475 246.819 -0.635
201712 -0.447 246.524 -0.599
201803 -0.389 249.554 -0.515
201806 -0.432 251.989 -0.566
201809 -0.392 252.439 -0.513
201812 -0.417 251.233 -0.548
201903 -0.590 254.202 -0.766
201906 -0.098 256.143 -0.126
201909 -0.281 256.759 -0.361
201912 -0.396 256.974 -0.509
202003 -0.305 258.115 -0.390
202006 -0.169 257.797 -0.216
202009 -0.203 260.280 -0.258
202012 -0.217 260.474 -0.275
202103 -0.236 264.877 -0.294
202106 -0.269 271.696 -0.327
202109 -0.262 274.310 -0.315
202112 -0.365 278.802 -0.432
202203 -0.386 287.504 -0.443
202206 -0.424 296.311 -0.473
202209 -0.421 296.808 -0.468
202212 -0.301 296.797 -0.335
202303 -0.373 301.836 -0.408
202306 -0.186 305.109 -0.201
202309 -0.132 307.789 -0.142
202312 -0.141 306.746 -0.152
202403 -0.159 312.332 -0.168
202406 -0.123 314.175 -0.129
202409 -0.151 315.301 -0.158
202412 -0.094 315.605 -0.098
202503 -0.086 319.799 -0.089
202506 -0.061 322.561 -0.062
202509 -0.068 324.800 -0.069
202512 -0.048 324.054 -0.049
202603 -0.066 330.213 -0.066

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-1.73 mean?
Microbot Medical (FRA:CY9D) has a Cyclically Adjusted FCF per Share of €-1.73 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Microbot Medical and its competitors.
Is Microbot Medical's Cyclically Adjusted FCF per Share too high?
Microbot Medical's current Cyclically Adjusted FCF per Share is €-1.73. Overall, Microbot Medical has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Microbot Medical's Cyclically Adjusted FCF per Share compare to STXS and DXR?
Microbot Medical's Cyclically Adjusted FCF per Share of €-1.73 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Microbot Medical and its competitors. Microbot Medical's current Cyclically Adjusted FCF per Share is €-1.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbot Medical stock overvalued right now?
Microbot Medical (FRA:CY9D) has a current Cyclically Adjusted FCF per Share of €-1.73. The current Cyclically Adjusted FCF per Share is €-1.73. Microbot Medical's overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Microbot Medical (FRA:CY9D), the current Cyclically Adjusted FCF per Share is €-1.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Microbot Medical Business Description

Other Exchanges MBOT:USA
Address 175 Derby Street, Building 27, Hingham, MA, USA, 02043
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
37GF Score

Get the complete analysis for FRA:CY9D

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.50
Price